Conversely, overexpression or pharmacological activation of SIRT3 was able to ameliorate or even block cardiac hypertrophy and interstitial fibrosis in response to pressure overload or hypertrophy agonist treatment (17, 29, 47). Here, SIRT3 is linked to cardiac hypertrophy.